Researchers will use a technique called single-cell RNA sequencing to identify surface markers specific to canine hemangiosarcoma cells as a first step toward the development of a more effective and precise therapy.

Researchers are studying if hemangiosarcoma subtypes influence how affected dogs respond to treatment – a step toward precision medicine for these patients.

Researchers will evaluate the potential of a novel drug derived from the feverfew plant to treat rapidly fatal canine cancers.

Researchers will study changes in microRNAs in the blood of dogs enrolled in the Golden Retriever Lifetime Study and diagnosed with hemangiosarcoma to identify early disease biomarkers.

Researchers are exploring if a protein found in some human cancers is also present in hemangiosarcoma tumors, and is a feasible therapy target.

Researchers will study the feasibility of using molecules called microRNAs as an early detection tool for hemangiosarcoma, an often-fatal cancer in dogs.